Clinical Trials Browser

Phase 2 × NSCLC × trilaciclib × Clear all

NCT06328049 2024-03-25

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Phase 2 Unknown

NSCLC